The predictive value of the sentinel lymph node biopsy in malignant melanoma of the head and neck in the Kiel patient collective
Laryngo-Rhino-Otologie · 01.05.2024 · 103 (S 02 S 02) · S215
DOI: 10.1055/s-0044-1784699 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laryngo-Rhino-Otologie, erschienen am 01.05.2024. Verfasst von Lukas Lükewille und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Sentinel lymph node biopsy (SLNB) has been an integral part of the diagnosis and staging of malignant melanoma (MM) since the end of the last millennium. The indication for a sentinel lymph node biopsy is a tumor thickness of 1.0 mm or more in the absence of locoregional or distant metastases. A sentinel lymph node biopsy can also be performed in the case of a thinner primary tumor (0.75-1.0 mm) if there is an increased risk of occult lymph node metastases, e.g. in the case of an increased mitosis rate, young age or ulceration of the primary tumor. The positivity of a SLN has a significant influence on the subsequent therapy and prognosis. The aim of this retrospective analysis is, among other things, to determine the predictive value of the biopsy against the background of the actual course of the patient's disease. Of particular interest is the frequency of SLNs without metastasis in patients who nevertheless develop metastases in the course of the disease. Materials and Methods For this purpose the data of patients who were treated in the ENT Clinic of the UKSH-Kiel between 2002 and 2020 are evaluated. For the time being 117 patient histories have been analyzed retrospectively.
Results
The detection rate of sentinel lymph nodes is 88.89% (111 of 117). Locoregional metastases occurred in 5 out of 81 patients with initially negative sentinel lymph nodes (6.17%). The sensitivity is 85.71%. The false-negative rate is 16.67%. The negative-predictive value is 94.7%.
Conclusion
SLNB continues to be an important component in the diagnosis of malignant melanoma in the head and neck region. However, the treating team should be aware of the limitations of the diagnostic procedure sometimes resulting in insufficient treatment. Publication History Article published online: 19 April 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Lükewille, L., Gonzalez, M., Elgar, S. Q., & Hoffmann, M. (2024). The predictive value of the sentinel lymph node biopsy in malignant melanoma of the head and neck in the Kiel patient collective. Laryngo-Rhino-Otologie, 103(S 02 S 02), S215. https://doi.org/10.1055/s-0044-1784699
Vancouver
Lükewille L, Gonzalez M, Elgar SQ, Hoffmann M. The predictive value of the sentinel lymph node biopsy in malignant melanoma of the head and neck in the Kiel patient collective. Laryngo-Rhino-Otologie. 2024;103(S 02 S 02):S215. doi:10.1055/s-0044-1784699
BibTeX
@article{Lkewille2024,
author = {Lükewille, Lukas and Gonzalez, Mireia and Elgar, Susanne Quabius and Hoffmann, Markus},
title = {The predictive value of the sentinel lymph node biopsy in malignant melanoma of the head and neck in the Kiel patient collective},
journal = {Laryngo-Rhino-Otologie},
year = {2024},
volume = {103},
number = {S 02 S 02},
pages = {S215},
doi = {10.1055/s-0044-1784699}
}
EUVIMED